Payment overview · 2025
General Payments
$15.45
1 reported records · 1 companies
Healthcare provider profile · identity verified
John Malcolm Beaman, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · RICHTON, MS · NPI 1932190774
Verified facts
What the public records show
CMS Open Payments records show John Malcolm Beaman, M.D. received $15.45 in general payments during 2025 across 1 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.45 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.45 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $15.45 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Omeprazole | Omeprazole | 467 | 144 |
| Levothyroxine Sodium | Levothyroxine Sodium | 379 | 106 |
| Losartan Potassium | Losartan Potassium | 336 | 103 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 332 | 88 |
| Amlodipine Besylate | Amlodipine Besylate | 267 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 231 | 62 |
| Gabapentin | Gabapentin | 227 | 76 |
| Metformin Hcl | Metformin Hcl | 215 | 71 |
| Tramadol Hcl | Tramadol Hcl | 195 | 50 |
| Atorvastatin Calcium | Atorvastatin Calcium | 193 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 177 | 58 |
| Pantoprazole Sodium | Pantoprazole Sodium | 173 | 44 |
| Meloxicam | Meloxicam | 154 | 52 |
| Eliquis | Apixaban | 152 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 142 | 47 |
| Clopidogrel | Clopidogrel Bisulfate | 134 | 36 |
| Lisinopril | Lisinopril | 119 | 34 |
| Famotidine | Famotidine | 116 | 36 |
| Carvedilol | Carvedilol | 112 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 108 | 42 |
| Amitriptyline Hcl | Amitriptyline Hcl | 96 | 26 |
| Allopurinol | Allopurinol | 94 | 30 |
| Furosemide | Furosemide | 90 | 35 |
| Jardiance | Empagliflozin | 90 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 89 | 25 |
| Pioglitazone Hcl | Pioglitazone Hcl | 89 | 22 |
| Metformin Hcl Er | Metformin Hcl | 85 | 26 |
| Synthroid | Levothyroxine Sodium | 85 | 26 |
| Clonidine Hcl | Clonidine Hcl | 79 | 27 |
| Farxiga | Dapagliflozin Propanediol | 79 | 26 |
| Glipizide Er | Glipizide | 79 | 28 |
| Zolpidem Tartrate | Zolpidem Tartrate | 78 | 20 |
| Azithromycin | Azithromycin | 77 | 63 |
| Montelukast Sodium | Montelukast Sodium | 75 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 74 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 71 | 21 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 71 | 48 |
| Ezetimibe | Ezetimibe | 70 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 69 | 53 |
| Levofloxacin | Levofloxacin | 69 | 56 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 65 | 21 |
| Potassium Chloride | Potassium Chloride | 64 | 21 |
| Diclofenac Sodium | Diclofenac Sodium | 62 | 20 |
| Donepezil Hcl | Donepezil Hcl | 61 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 60 | 24 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 58 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 56 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 56 | 22 |
| Mupirocin | Mupirocin | 56 | 19 |
| Sertraline Hcl | Sertraline Hcl | 56 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 16 |
| Alprazolam | Alprazolam | 49 | suppressed |
| Cefdinir | Cefdinir | 48 | 44 |
| Fluconazole | Fluconazole | 48 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 13 |
| Simvastatin | Simvastatin | 48 | 13 |
| Propranolol Hcl | Propranolol Hcl | 47 | 18 |
| Ozempic | Semaglutide | 46 | suppressed |
| Clonazepam | Clonazepam | 45 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 45 | 11 |
| Trazodone Hcl | Trazodone Hcl | 45 | 15 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 41 | 11 |
| Pregabalin | Pregabalin | 41 | 14 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 39 | suppressed |
| Ondansetron Odt | Ondansetron | 39 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | 13 |
| Meclizine Hcl | Meclizine Hcl | 38 | 20 |
| Naproxen | Naproxen | 38 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 37 | 16 |
| Sumatriptan Succinate | Sumatriptan Succinate | 35 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 34 | suppressed |
| Prednisone | Prednisone | 34 | 19 |
| Atenolol | Atenolol | 33 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 32 | 11 |
| Pentoxifylline | Pentoxifylline | 32 | 11 |
| Valacyclovir | Valacyclovir Hcl | 32 | 14 |
| Clarithromycin | Clarithromycin | 31 | 27 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 31 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 30 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 24 |
| Methylprednisolone | Methylprednisolone | 29 | 26 |
| Finasteride | Finasteride | 28 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 28 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 27 | 14 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 27 | suppressed |
| Repatha Sureclick | Evolocumab | 27 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 26 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 26 | suppressed |
| Spironolactone | Spironolactone | 26 | 14 |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Celecoxib | Celecoxib | 25 | suppressed |
| Glimepiride | Glimepiride | 25 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 24 | 23 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | suppressed |
| Mounjaro | Tirzepatide | 23 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 23 | suppressed |
| Estradiol | Estradiol | 22 | suppressed |
| Januvia | Sitagliptin Phosphate | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 20 | suppressed |
| Trimethoprim | Trimethoprim | 20 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 18 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Sucralfate | Sucralfate | 18 | suppressed |
| Victoza 3-Pak | Liraglutide | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | 13 |
| Lovastatin | Lovastatin | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Aripiprazole | Aripiprazole | 16 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | 15 |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 14 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Repatha Syringe | Evolocumab | 14 | suppressed |
| Trulicity | Dulaglutide | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Cephalexin | Cephalexin | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 11 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Nadolol | Nadolol | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.45 · 1 records | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error